The global optical genome mapping industry will reach a valuation of USD 167.0 million in 2024, attributed to factors including regulatory harmonization and standardization. The trend is set to create new opportunities for the market, leading to a projected CAGR of 23.5% between 2024 and 2034, and reaching a total valuation of approximately USD 1.3 billion …